Send feedback

CEP164 p.Pro495fs

c.1481dup · rs752518735 · VCV1009382

Pathogenic/Likely pathogenic Multiple submitters
Classification
Pathogenic/Likely pathogenic
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
Consequence
frameshift
predicted LoF
gnomAD v4.1
Rare
very rare (popmax 0.00899%, eas)
Conditions
1
nephronophthisis 15

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Consequenceframeshiftpredicted loss-of-function
NMDpredictedpremature termination codon in exon 13 of 33
Splicing
SpliceAI—not assessed · substitutions only
Constraint at this position
ConservationphyloP 2.5GERP -0.84, phastCons 0.99
Overall
CADD22.4PHRED · no single calibrated threshold — expert panels disagree

Predicted loss-of-function is descriptive, not an applied PVS1 code.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00899% East Asian · 4/44,470 alleles
Filtering AF 0.003% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00181%
Overall 0.0025% 40/1,602,736 alleles · very rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.0271% 3,696
East Asiangrpmax 0.00899% 11,117
Admixed American 0.0051% 19,613
Remaining individualsnot grpmax-eligible 0.00161% 61,984
African / African-American 0.00134% 74,654
European (non-Finnish) 0.00119% 83,912

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CEP164
Protein
p.Pro495fs
Coding
c.1481dup
MANE Select
NM_014956
dbSNP
rs752518735
Type
Duplication
Location
chr11:117381770 (GRCh38)
Gene constraint
LOEUF 1.009 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 63.08 · 4 PDB
Residue 495
the 'disordered' region
Full CEP164 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

nephronophthisis 15 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Senior-Loken syndrome (Orphanet):

Inheritance
Autosomal recessive
Onset
Adolescent, Adult, Childhood, Infancy
Prevalence
1-9 / 1 000 000 (Worldwide)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cep164-p-pro495fs (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown